By SaharaNews247 Editorial Team
Over 44,000 people are on HIV treatment in Kano State, Nigeria, but donor funding is shrinking fast. Experts warn of risks to sustainability, treatment gaps, and vulnerable populations. Here’s what the latest data reveals.
Introduction
Kano State is at a critical point in its fight against HIV/AIDS. Recent reports have highlighted a significant discrepancy in treatment numbers and growing concerns over the impact of declining donor support.
While the Kano State Coordinator for the National Agency for the Control of AIDS (NACA), Dr. Usman Bashir, reports 33,000 people currently receiving HIV treatment, NGO data suggests that over 44,000 individuals were on treatment by December 2024. This gap in figures has sparked calls for improved data management and transparency.
Understanding the Discrepancy in Treatment Numbers
Data accuracy is essential for effective public health planning. In Kano’s case:
Official Government Data (NACA) — 33,000 active patients on treatment in 2025.
NGO Records (Save Lives Sustainable & Counselling Initiative) — 44,000+ patients as of December 2024.
Such a variance could be due to:
Delays in updating central treatment databases.
Loss to follow-up of patients not yet removed from records.
Differences in counting methods between NGOs and state agencies.
Experts warn that without unified, up-to-date statistics, treatment stock planning, resource allocation, and monitoring could be compromised.
The Bigger Picture: Declining Donor Support
For over two decades, Nigeria’s HIV program relied heavily on donor funding from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund, and other international partners.
Now, funding is shrinking.
PEPFAR has reduced annual allocations, shifting focus to countries with higher per-capita HIV burdens.
The Global Fund’s new funding cycle has lower disbursements for Nigeria, citing the need for domestic ownership of HIV programs.
NGOs in Kano report that some community HIV awareness projects have been scaled down or halted due to lack of funds.
Dr. Bashir warns:
“Without sustainable domestic funding, we risk reversing decades of progress in the fight against HIV.”
Nigeria’s National HIV Landscape
According to NACA’s 2024 estimates:
2 million Nigerians are living with HIV.
1.6 million are on treatment — meaning 400,000 remain untreated.
Nigeria recorded 75,000 new HIV infections in 2023.
45,000 AIDS-related deaths occurred in the same year.
Why Declining Donor Support Is a Threat
Kano State, with an estimated 53,972 people living with HIV, is among the top five most affected states in Nigeria.
1. Treatment Continuity at Risk — Without consistent funding, drug shortages may occur.
2. Prevention Programs May Shrink — Especially those targeting mother-to-child transmission and key populations.
3. Testing and Early Diagnosis Could Decline — Reduced outreach will delay diagnosis, leading to late-stage presentations.
4. Community Support Services May Disappear — Peer counseling, adherence clubs, and stigma-reduction programs need stable funding.
Local Solutions Emerging
To address funding gaps, Nigeria is:
Encouraging local manufacturing of HIV test kits (e.g., Codix Bio Ltd in Lagos).
Allocating N300 billion in the 2025 federal budget to healthcare, with HIV treatment remaining free.
Promoting public-private partnerships for sustainable supply chains.
What Needs to Be Done
Reconcile Data Discrepancies — Create a unified real-time HIV treatment database.
Increase Domestic Funding — Federal and state budgets must allocate more to HIV programs.
Strengthen Supply Chains — Reduce dependency on imported test kits and medicines.
Prioritize Vulnerable Groups — Ensure pregnant women, children, and key populations have uninterrupted access to care.
Community Engagement — Reinvigorate grassroots HIV awareness to combat stigma and boost testing rates.
Expert Insight
Public health analyst Dr. Ngozi Okafor notes:
“Donor withdrawal is inevitable; the question is whether Nigeria will step up to replace those funds before the gaps start costing lives.”
Frequently Asked Questions (FAQ)
1. Why is there a difference between NACA and NGO HIV treatment figures in Kano?
Data collection methods, reporting timelines, and record updates often differ between agencies, causing discrepancies.
2. Will HIV treatment remain free in Nigeria?
Yes. The Nigerian government has reaffirmed its commitment to free HIV treatment despite reduced donor support.
3. How will donor cuts affect HIV services in Nigeria?
Possible effects include reduced prevention programs, fewer community outreach services, and potential treatment interruptions if domestic funding is insufficient.
4. What can be done to sustain HIV programs in Kano?
Increasing domestic funding, improving data management, local manufacturing of supplies, and community-based interventions are key.
Conclusion
Kano’s HIV treatment journey is a microcosm of Nigeria’s broader HIV battle — significant progress shadowed by funding uncertainty. Accurate data, domestic investment, and community resilience will determine whether the gains of the past decades are protected or lost.
